THE TREATMENT OF SCHIZOPHRENIA WITH THE ADDITION OF ATYPICAL ANTIPSYCHOTIC MEDICATION TO TRAVEL THERAPY

被引:0
|
作者
Liu, Deng [1 ]
机构
[1] Wuhan Tech Coll Commun, Wuhan 430065, Peoples R China
关键词
D O I
10.1093/schbul/sbaf007.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
5
引用
收藏
页码:S3 / S3
页数:1
相关论文
共 50 条
  • [31] Antipsychotic medication and treatment outcome in schizophrenia outpatient care
    Seemann, U
    Schwarz, C
    Janssen, B
    Kissling, W
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S297 - S297
  • [32] Impact of atypical antipsychotic medication on quality of life in patients with schizophrenia: a preliminary report
    Kaneda, Y
    Imakura, A
    Fujii, A
    Ohmori, T
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S17 - S17
  • [33] Atypical antipsychotic drugs for schizophrenia
    Luh, JY
    MAYO CLINIC PROCEEDINGS, 2003, 78 (03) : 381 - 382
  • [34] Lurasidone: An Atypical Antipsychotic for Schizophrenia
    Risbood, Vineeta
    Lee, Jennifer R.
    Roche-Desilets, Jennifer
    Fuller, Matthew A.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 1033 - 1046
  • [35] Atypical antipsychotic and compliance in schizophrenia
    Hale, AS
    NORDIC JOURNAL OF PSYCHIATRY, 1995, 49 : 31 - 39
  • [36] Antipsychotic medication adherence in schizophrenia
    Byerly, Matthew J.
    Nakonezny, Paul A.
    Lescouflair, Emmeline
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2007, 30 (03) : 437 - +
  • [37] Antipsychotic medication in schizophrenia: a review
    Lally, John
    MacCabe, James H.
    BRITISH MEDICAL BULLETIN, 2015, 114 (01) : 169 - 179
  • [38] Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
    Douglas Faries
    Haya Ascher-Svanum
    Baojin Zhu
    Christoph Correll
    John Kane
    BMC Psychiatry, 5
  • [39] Prevalence of hyperprolactinemia in schizophrenia: Association with typical and atypical antipsychotic treatment
    Montgomery, J
    Winterbottom, E
    Jessani, M
    Kohegyi, E
    Fulmer, J
    Seamonds, B
    Josiassen, RC
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (11) : 1491 - 1498
  • [40] Factors affecting cost of schizophrenia treatment with atypical antipsychotic agents
    Law, W
    Hui, H
    Young, W
    You, JH
    VALUE IN HEALTH, 2005, 8 (06) : A205 - A205